ArticleFrontiers in bioengineering and biotechnology2018

Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells-Single Center Experience.

Maja Česen Mazič et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.